$PMN
ProMIS Neurosciences Inc

2022 Q4 Form 10-Q Financial Statement

#000110465922117657 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4
Revenue $0.00 $0.00 $11.31K
YoY Change -100.0% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.138M $1.484M $2.670M
YoY Change -19.91% 73.98% 520.95%
% of Gross Profit
Research & Development $6.384M $4.571M $3.858M
YoY Change 65.47% 283.16% 1383.97%
% of Gross Profit
Depreciation & Amortization $1.550K $1.883K $12.37K
YoY Change -87.47% -87.75% 23.7%
% of Gross Profit
Operating Expenses $8.523M $6.054M $6.528M
YoY Change 30.55% 195.96% 846.15%
Operating Profit -$6.054M
YoY Change 192.35%
Interest Expense $1.257M $97.26K $3.516M
YoY Change -64.25% -90.98%
% of Operating Profit
Other Income/Expense, Net $97.26K
YoY Change -88.69%
Pretax Income -$7.266M -$5.957M -$2.926M
YoY Change 148.34% 519.23% 324.01%
Income Tax
% Of Pretax Income
Net Earnings -$7.266M -$6.000M -$2.926M
YoY Change 148.34% 523.71% 324.01%
Net Earnings / Revenue -25868.08%
Basic Earnings Per Share -$0.85
Diluted Earnings Per Share -$0.86 -$0.85 -$405.6K
COMMON SHARES
Basic Shares Outstanding 8.579M 7.196M
Diluted Shares Outstanding 7.196M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.907M $3.951M $21.49M
YoY Change -72.51% -85.12% 1908.04%
Cash & Equivalents $5.876M $3.921M $16.94M
Short-Term Investments $31.01K $30.54K $42.08K
Other Short-Term Assets $996.7K $1.408M $871.5K
YoY Change 14.36% -40.44% 570.4%
Inventory
Prepaid Expenses
Receivables $61.62K
Other Receivables $0.00
Total Short-Term Assets $6.903M $5.359M $17.71M
YoY Change -61.03% -81.6% 1328.59%
LONG-TERM ASSETS
Property, Plant & Equipment $321.00 $788.00 $4.671K
YoY Change -93.13% -98.69% -95.33%
Goodwill
YoY Change
Intangibles $20.84K $21.73K $27.61K
YoY Change -24.54%
Long-Term Investments $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $21.16K $22.52K $32.29K
YoY Change -34.46% -76.75% -76.94%
TOTAL ASSETS
Total Short-Term Assets $6.903M $5.359M $17.71M
Total Long-Term Assets $21.16K $22.52K $32.29K
Total Assets $6.925M $5.382M $17.75M
YoY Change -60.98% -81.58% 1186.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.975M $1.795M $409.0K
YoY Change 627.51% 210.11% -26.97%
Accrued Expenses $3.438M $1.304M $520.1K
YoY Change 560.97% 281.29% 766.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.413M $3.099M $929.1K
YoY Change 590.26% 41.35% -61.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $4.943M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.859M $1.553M $8.864M
YoY Change -79.02% -87.65%
Total Long-Term Liabilities $1.859M $1.553M $13.81M
YoY Change -86.53% -91.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.413M $3.099M $929.1K
Total Long-Term Liabilities $1.859M $1.553M $13.81M
Total Liabilities $8.272M $4.652M $12.09M
YoY Change -31.56% -76.27% 403.61%
SHAREHOLDERS EQUITY
Retained Earnings -$80.25M -$73.00M -$62.19M
YoY Change 29.04%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.348M $729.8K $5.660M
YoY Change
Total Liabilities & Shareholders Equity $6.925M $5.382M $17.75M
YoY Change -60.98% -81.58% 1186.0%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income -$7.266M -$6.000M -$2.926M
YoY Change 148.34% 523.71% 324.01%
Depreciation, Depletion And Amortization $1.550K $1.883K $12.37K
YoY Change -87.47% -87.75% 23.7%
Cash From Operating Activities -$4.554M -$4.636M -$5.720M
YoY Change -20.39% 41.88% 515.07%
INVESTING ACTIVITIES
Capital Expenditures -$40.00 $30.00 -$6.180K
YoY Change -99.35% -102.0% -38.2%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $128.0K
YoY Change -100.0%
Cash From Investing Activities $40.00 $30.00 $121.8K
YoY Change -99.97% -102.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.495M 534.7K
YoY Change 1114.7% -67.2%
NET CHANGE
Cash From Operating Activities -4.554M -4.636M -5.720M
Cash From Investing Activities 40.00 30.00 121.8K
Cash From Financing Activities 6.495M 534.7K
Net Change In Cash 1.941M -4.636M -5.064M
YoY Change -138.33% -123.66% -823.39%
FREE CASH FLOW
Cash From Operating Activities -$4.554M -$4.636M -$5.720M
Capital Expenditures -$40.00 $30.00 -$6.180K
Free Cash Flow -$4.554M -$4.636M -$5.714M
YoY Change -20.31% 41.94% 521.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5310483
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.44
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7195529
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5919485
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.44
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7195529
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5310483
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7195529
CY2019Q3 pmn Related Party Transaction Additional Term Of Agreement
RelatedPartyTransactionAdditionalTermOfAgreement
P1Y
CY2022Q1 pmn Related Party Transaction Additional Term Of Agreement
RelatedPartyTransactionAdditionalTermOfAgreement
P3Y
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.44
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5919485
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7195529
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5310483
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-796658
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
397480
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1665099
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15867936
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-102558
us-gaap Net Income Loss
NetIncomeLoss
-7545497
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
7820703
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5660058
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
348861
pmn Stock Issued During Period Value Conversion Of Convertible Debt And Derivative Liability
StockIssuedDuringPeriodValueConversionOfConvertibleDebtAndDerivativeLiability
5600000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3920742
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16943905
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4842
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4842
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4842
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
70000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
dei Entity Central Index Key
EntityCentralIndexKey
0001374339
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
ProMIS Neurosciences Inc.
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7195529
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
70000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 pmn Fair Value Assets Liabilities Level2 Transfers Amount
FairValueAssetsLiabilitiesLevel2TransfersAmount
0
CY2021Q4 pmn Fair Value Assets Liabilities Level2 Transfers Amount
FairValueAssetsLiabilitiesLevel2TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022Q1 pmn Related Party Transaction Additional Term Of Agreement
RelatedPartyTransactionAdditionalTermOfAgreement
P3Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41429
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0647155
dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 200, 1920 Yonge Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Toronto
dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
M4S 3E2
dei City Area Code
CityAreaCode
416
dei Local Phone Number
LocalPhoneNumber
847-6898
dei Security12b Title
Security12bTitle
Common Shares, no par value per share
dei Trading Symbol
TradingSymbol
PMN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8579284
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
30539
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
33248
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1407864
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
737316
CY2022Q3 us-gaap Assets Current
AssetsCurrent
5359145
CY2021Q4 us-gaap Assets Current
AssetsCurrent
17714469
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
788
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4671
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21732
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27614
CY2022Q3 us-gaap Assets
Assets
5381665
CY2021Q4 us-gaap Assets
Assets
17746754
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1794807
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
408981
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1303908
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
520093
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3098715
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
929074
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
3906057
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
5379878
CY2022Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
1553186
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
1871687
CY2022Q3 us-gaap Liabilities
Liabilities
4651901
CY2021Q4 us-gaap Liabilities
Liabilities
12086696
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
70000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
70000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
70000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7195529
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7195529
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
0
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73988039
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68039178
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-270316
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-187919
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72987959
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62191201
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
729764
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5660058
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5381665
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17746754
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4570562
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
805392
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9702978
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1964978
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
6054135
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1779285
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1483573
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1265486
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5154324
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
2070878
us-gaap Operating Expenses
OperatingExpenses
14857302
us-gaap Operating Expenses
OperatingExpenses
3744263
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6054135
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2070878
us-gaap Operating Income Loss
OperatingIncomeLoss
-14857302
us-gaap Operating Income Loss
OperatingIncomeLoss
-3744263
CY2021Q3 us-gaap Interest Expense
InterestExpense
140912
us-gaap Interest Expense
InterestExpense
282064
us-gaap Interest Expense
InterestExpense
276317
CY2022Q3 pmn Gain Loss From Change In Fair Value Of Financial Instruments
GainLossFromChangeInFairValueOfFinancialInstruments
61407
CY2021Q3 pmn Gain Loss From Change In Fair Value Of Financial Instruments
GainLossFromChangeInFairValueOfFinancialInstruments
997095
pmn Gain Loss From Change In Fair Value Of Financial Instruments
GainLossFromChangeInFairValueOfFinancialInstruments
2972272
pmn Gain Loss From Change In Fair Value Of Financial Instruments
GainLossFromChangeInFairValueOfFinancialInstruments
-3526590
pmn Gains Losses On Extinguishment Of Debt And Derivative Liability
GainsLossesOnExtinguishmentOfDebtAndDerivativeLiability
1307421
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
35853
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4052
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
62915
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1673
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
97260
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
860235
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4060544
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3801234
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5956875
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1210643
us-gaap Net Income Loss
NetIncomeLoss
-10796758
us-gaap Net Income Loss
NetIncomeLoss
-7545497
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-131874
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
42659
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-82397
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-102558
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6088749
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1167984
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10879155
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7648055
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.44
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7195529
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5919485
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7195529
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5310483
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-796658
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-102558
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
7820703
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5660058
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
348861
pmn Stock Issued During Period Value Conversion Of Convertible Debt And Derivative Liability
StockIssuedDuringPeriodValueConversionOfConvertibleDebtAndDerivativeLiability
5600000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-82397
us-gaap Net Income Loss
NetIncomeLoss
-10796758
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
729764
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-7068878
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
189629
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1665099
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15867936
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
42659
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6709929
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-131874
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5956875
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
729764
us-gaap Profit Loss
ProfitLoss
-10796758
us-gaap Profit Loss
ProfitLoss
-7545497
us-gaap Share Based Compensation
ShareBasedCompensation
348861
us-gaap Share Based Compensation
ShareBasedCompensation
397480
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-367649
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-107905
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2643123
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-326741
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31141
us-gaap Depreciation
Depreciation
5771
us-gaap Depreciation
Depreciation
32339
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
247046
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
241558
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3886
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3959
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2373
pmn Gains Losses On Extinguishment Of Debt And Derivative Liability
GainsLossesOnExtinguishmentOfDebtAndDerivativeLiability
1307421
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1518327
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16551
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
883931
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
223937
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-405508
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12480255
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5258703
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2024
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1187
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2024
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1187
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6915199
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15867936
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2739221
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25522356
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-540884
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-174228
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1665099
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-82397
us-gaap Net Income Loss
NetIncomeLoss
-10796758
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
189629
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15867936
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
42659
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1210643
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
7820703
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6709929
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
108584
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-131874
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5956875
us-gaap Share Based Compensation
ShareBasedCompensation
348861
us-gaap Share Based Compensation
ShareBasedCompensation
397480
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-367649
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-107905
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2643123
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-3601082
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-326741
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31141
us-gaap Depreciation
Depreciation
5771
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
241558
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3886
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3959
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2373
pmn Gains Losses On Extinguishment Of Debt And Derivative Liability
GainsLossesOnExtinguishmentOfDebtAndDerivativeLiability
1307421
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
781683
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1903741
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1518327
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2024
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1187
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6915199
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13023163
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20088238
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16943905
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3920742
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20895125
us-gaap Interest Paid Net
InterestPaidNet
87069
pmn Issuance Of Compensation Warrants In Consideration Of Issuance Costs
IssuanceOfCompensationWarrantsInConsiderationOfIssuanceCosts
957947
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6000000.0
us-gaap Net Income Loss
NetIncomeLoss
-10800000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73000000.0
CY2021Q4 pmn Fair Value Assets Liabilities Level1 Transfers Amount
FairValueAssetsLiabilitiesLevel1TransfersAmount
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13023163
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20088238
pmn Conversion Of Convertible Debt And Derivative Liability To Series1 Convertible Preferred Shares
ConversionOfConvertibleDebtAndDerivativeLiabilityToSeries1ConvertiblePreferredShares
5600000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16943905
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
806887
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3920742
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20895125
us-gaap Interest Paid Net
InterestPaidNet
87069
pmn Issuance Of Compensation Warrants In Consideration Of Issuance Costs
IssuanceOfCompensationWarrantsInConsiderationOfIssuanceCosts
957947
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6000000.0
us-gaap Net Income Loss
NetIncomeLoss
-10800000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73000000.0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q3 pmn Fair Value Assets Liabilities Level1 Transfers Amount
FairValueAssetsLiabilitiesLevel1TransfersAmount
0
CY2022Q2 pmn Stockholders Equity Note Reverse Stock Split Conversion Ratio
StockholdersEquityNoteReverseStockSplitConversionRatio
60
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 36pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">The preparation of financial statements in conformity with GAAP requires management to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made in the accompanying unaudited condensed consolidated financial statements include, but are not limited to, the accrual for research and development expenses and the valuation of warrant liabilities and embedded derivative liabilities. Actual results could differ from those estimates, and such differences could be material to the unaudited condensed consolidated financial statements.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q3 pmn Fair Value Assets Liabilities Level1 Transfers Amount
FairValueAssetsLiabilitiesLevel1TransfersAmount
0
CY2021Q4 pmn Fair Value Assets Liabilities Level1 Transfers Amount
FairValueAssetsLiabilitiesLevel1TransfersAmount
0
CY2022Q3 pmn Prepaid Upfront Research Payments Current
PrepaidUpfrontResearchPaymentsCurrent
85675
CY2021Q4 pmn Prepaid Upfront Research Payments Current
PrepaidUpfrontResearchPaymentsCurrent
554878
CY2022Q3 us-gaap Prepaid Taxes
PrepaidTaxes
60711
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
48690
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
700344
CY2022Q3 pmn Prepaid Consultants Current
PrepaidConsultantsCurrent
9958
CY2021Q4 pmn Prepaid Consultants Current
PrepaidConsultantsCurrent
69915
CY2022Q3 pmn Prepaid License Fee Current
PrepaidLicenseFeeCurrent
48555
CY2021Q4 pmn Prepaid License Fee Current
PrepaidLicenseFeeCurrent
19754
CY2022Q3 us-gaap Deposit Assets
DepositAssets
12711
CY2021Q4 us-gaap Deposit Assets
DepositAssets
6839
CY2022Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
470054
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
4573
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
4387
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1407864
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
737316
CY2022Q3 pmn Prepaid Upfront Research Payments Current
PrepaidUpfrontResearchPaymentsCurrent
85675
CY2021Q4 pmn Prepaid Upfront Research Payments Current
PrepaidUpfrontResearchPaymentsCurrent
554878
CY2022Q3 us-gaap Prepaid Taxes
PrepaidTaxes
60711
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
48690
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
700344
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
32853
CY2022Q3 pmn Prepaid Dues And Subscriptions Current
PrepaidDuesAndSubscriptionsCurrent
15283
CY2022Q3 pmn Prepaid Consultants Current
PrepaidConsultantsCurrent
9958
CY2021Q4 pmn Prepaid Consultants Current
PrepaidConsultantsCurrent
69915
CY2022Q3 pmn Prepaid License Fee Current
PrepaidLicenseFeeCurrent
48555
CY2021Q4 pmn Prepaid License Fee Current
PrepaidLicenseFeeCurrent
19754
CY2021Q4 us-gaap Deposit Assets
DepositAssets
6839
CY2022Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
470054
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
4573
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
4387
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
737316
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79103
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84060
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78315
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
79389
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
788
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4671
CY2022Q3 us-gaap Depreciation
Depreciation
1883
CY2021Q3 us-gaap Depreciation
Depreciation
10862
CY2012Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
100000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
72577
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
79015
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
50845
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
51401
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21732
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
27614
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1263
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1322
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3886
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3959
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1211
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4842
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1153
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84060
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78315
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
79389
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
788
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4671
CY2021Q3 us-gaap Depreciation
Depreciation
10862
us-gaap Depreciation
Depreciation
5771
us-gaap Depreciation
Depreciation
32339
CY2012Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
100000
CY2012Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
79015
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
50845
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
51401
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21732
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3959
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1211
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4842
CY2022Q3 pmn Accrued Legal Fees Current
AccruedLegalFeesCurrent
212161
CY2021Q4 pmn Accrued Legal Fees Current
AccruedLegalFeesCurrent
171777
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
42544
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
123026
CY2022Q3 pmn Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
869975
CY2021Q4 pmn Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
106845
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
54398
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
179228
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
64047
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1303908
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
520093
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2741058
CY2022Q3 pmn Common Stock Fair Value Per Share On Conversion Date
CommonStockFairValuePerShareOnConversionDate
0.08
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7195529
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7195529
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
70000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
pmn Number Of Votes Per Common Share
NumberOfVotesPerCommonShare
1
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
70000000
CY2022Q3 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.10
pmn Preferred Stock Convertible Conversion Price After Reverse Stock Split
PreferredStockConvertibleConversionPriceAfterReverseStockSplit
6.00
CY2022Q3 pmn Stockholders Equity Note Reverse Stock Split Conversion Ratio
StockholdersEquityNoteReverseStockSplitConversionRatio
60
pmn Minimum Gross Proceeds From Sale Of Equity Securities
MinimumGrossProceedsFromSaleOfEquitySecurities
30000000
CY2021Q3 pmn Payments Of Warrants Issuance Costs
PaymentsOfWarrantsIssuanceCosts
444558
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1458496
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1458496
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1560588
CY2022Q3 us-gaap Convertible Preferred Stock Shares Reserved For Future Issuance
ConvertiblePreferredStockSharesReservedForFutureIssuance
1166667
CY2021Q4 pmn Convertible Debt Shares Reserved For Future Issuance
ConvertibleDebtSharesReservedForFutureIssuance
1166667
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1043025
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
738037
CY2022Q3 pmn Deferred Share Units Outstanding
DeferredShareUnitsOutstanding
1061
CY2021Q4 pmn Deferred Share Units Outstanding
DeferredShareUnitsOutstanding
1061
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
396080
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
281798
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4065329
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3748151
pmn Number Of Votes Per Common Share
NumberOfVotesPerCommonShare
1
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
70000000
CY2022Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
6.00
CY2022Q3 pmn Value Divided To Ascertain Shares Convertible
ValueDividedToAscertainSharesConvertible
0.10
CY2022Q3 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.10
pmn Preferred Stock Convertible Conversion Price After Reverse Stock Split
PreferredStockConvertibleConversionPriceAfterReverseStockSplit
6.00
CY2022Q3 pmn Stockholders Equity Note Reverse Stock Split Conversion Ratio
StockholdersEquityNoteReverseStockSplitConversionRatio
60
pmn Minimum Gross Proceeds From Sale Of Equity Securities
MinimumGrossProceedsFromSaleOfEquitySecurities
30000000
CY2021Q3 pmn Payments Of Warrants Issuance Costs
PaymentsOfWarrantsIssuanceCosts
444558
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1458496
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
738037
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.15
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2231253
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
360000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
55012
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.98
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1043025
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.53
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2377874
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
648698
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.32
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2073899
pmn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
2102400
pmn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
918822
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
738037
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.15
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2231253
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.54
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.53
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
648698
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.32
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2073899
pmn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
2102400
pmn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
918822
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q3 us-gaap Share Price
SharePrice
5.84
CY2021Q3 us-gaap Share Price
SharePrice
6.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9534
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0271
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0081
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y1M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
16666
CY2022Q3 pmn Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Redeemable Per Unit
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesRedeemablePerUnit
1
CY2021Q3 us-gaap Share Price
SharePrice
6.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9534
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9443
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0271
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0081
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Price
SharePrice
5.84
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
16666
CY2022Q3 pmn Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Redeemable Per Unit
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesRedeemablePerUnit
1
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
348861
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
397480
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2382998
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y4M24D
CY2016Q2 pmn Related Party Transaction Term Of Agreement
RelatedPartyTransactionTermOfAgreement
P3Y
CY2018Q1 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
892500
CY2018Q3 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
1130000
CY2019Q1 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
2130000
CY2019Q1 pmn Related Party Transaction Additional Term Of Agreement
RelatedPartyTransactionAdditionalTermOfAgreement
P2Y
CY2019Q3 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
2630000
CY2021Q4 pmn Related Party Transaction Additional Grant Commitment
RelatedPartyTransactionAdditionalGrantCommitment
800000
CY2022Q3 pmn Collaborative Arrangement Accruals For Royalty Payments
CollaborativeArrangementAccrualsForRoyaltyPayments
0
us-gaap Short Term Lease Cost
ShortTermLeaseCost
49854
us-gaap Short Term Lease Cost
ShortTermLeaseCost
15909
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9553
CY2018Q3 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
1130000
CY2019Q1 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
2130000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
108584
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
189629
CY2016Q2 pmn Related Party Transaction Term Of Agreement
RelatedPartyTransactionTermOfAgreement
P3Y
CY2018Q1 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
892500
CY2019Q1 pmn Related Party Transaction Additional Term Of Agreement
RelatedPartyTransactionAdditionalTermOfAgreement
P2Y
CY2019Q3 pmn Related Party Transaction Funding Commitment
RelatedPartyTransactionFundingCommitment
2630000
CY2021Q4 pmn Related Party Transaction Additional Grant Commitment
RelatedPartyTransactionAdditionalGrantCommitment
800000
CY2022Q1 pmn Related Party Transaction Additional Grant Commitment
RelatedPartyTransactionAdditionalGrantCommitment
3430000
us-gaap Related Party Costs
RelatedPartyCosts
409268
us-gaap Related Party Costs
RelatedPartyCosts
233115
us-gaap Short Term Lease Cost
ShortTermLeaseCost
49854
us-gaap Short Term Lease Cost
ShortTermLeaseCost
15909
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9553
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10879155
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7648055
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7195529
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5310483
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5310483
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.44
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10879155
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7648055
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7195529
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3669249
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3417637

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001104659-22-117657-index-headers.html Edgar Link pending
0001104659-22-117657-index.html Edgar Link pending
0001104659-22-117657.txt Edgar Link pending
0001104659-22-117657-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pmn-20220930.xsd Edgar Link pending
pmn-20220930x10q.htm Edgar Link pending
pmn-20220930xex31d1.htm Edgar Link pending
pmn-20220930xex31d2.htm Edgar Link pending
pmn-20220930xex32d1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
pmn-20220930_cal.xml Edgar Link unprocessable
pmn-20220930_def.xml Edgar Link unprocessable
pmn-20220930_lab.xml Edgar Link unprocessable
pmn-20220930_pre.xml Edgar Link unprocessable
pmn-20220930x10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending